Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04520373 · ClinicalTrials.gov registry record · Phase 2
Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients
A Phase 2 study of Spinal Cord Injuries and Paralysis, sponsored by Mayo Clinic.
- Active
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04520373 is a Phase 2 study of Spinal Cord Injuries and Paralysis that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04520373, a Phase 2 study of Spinal Cord Injuries and Paralysis, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate the safety and potential therapeutic effects of autologous, culture-expanded, adipose derived mesenchymal stem cell intrathecal injections in the treatment of spinal cord injury.
Conditions Studied
Interventions
- OTHER Best Medical Management: Occupational and Physical Therapy
- BIOLOGICAL Autologous, Adipose Derived Mesenchymal Stem Cells
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-06-25 |
| Est. Completion | 2026-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04520373
The ClinicalTrials.gov registry entry for NCT04520373 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (34% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Best Medical Management: Occupational and Physical Therapy is the first listed.
NCT04520373 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04520373 about?
NCT04520373 is a clinical study titled "Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients". The purpose of this research study is to investigate the safety and potential therapeutic effects of autologous, culture-expanded, adipose derived mesenchymal stem cell intrathecal injections in the treatment of spinal cord injury.
What is the current status of trial NCT04520373?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2020-06-25. Estimated completion is 2026-07.
What conditions does trial NCT04520373 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Paralysis.
What interventions are being tested in trial NCT04520373?
The interventions under investigation include: Best Medical Management: Occupational and Physical Therapy (OTHER), Autologous, Adipose Derived Mesenchymal Stem Cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT04520373?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04520373 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Epidural Stimulation and Resistance Training After SCI
RECRUITING · Phase 2
-
Intravesical LGG VS Saline Bladder Wash RCT
RECRUITING · Phase 2
-
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
RECRUITING · Phase 2
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
RECRUITING · Phase 2
-
Effects of 5HTP on the Injured Human Spinal Cord
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.